efineptakin alfa,NT-I7
genexine,neoimmunetech
['efineptakin', 'neoimmunetech']
#neoimmunetech's lead asset #nti7 (#efineptakinalfa) shows preliminary #anticancer activity in combination with #checkpointinhibitors $asco22 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.